Anteris terminates v2v development deal, pays $400K break fee

Anteris Technologies Global Corp.

Notified v2vmedtech of discontinuation of development contributions after Stage 1 completion.
Break fee of $400,000 payable to v2v; no further contribution obligations.
v2v shareholders may either buy back Anteris' equity at cost or reduce it to capped minority.
Related Development Agreement will terminate upon break fee payment.
Company expects no material adverse effect on consolidated financial position.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.95

Anteris Technologies Global Corp. terminated Contribution and Stock Purchase Agreement with v2vmedtech, inc. valued at break fee of $400,000 (effective 2026-04-28).

Action: termination
Agreement: equity purchase
Counterparty: v2vmedtech, inc.
Value: break fee of $400,000
Effective: 2026-04-28

Exact text from the filing

On April 28 , 2026, Anteris Technologies Global Corp., through its wholly owned subsidiary, Anteris Technologies Corporation (the “Company”), notified v2vmedtech, inc. (“v2v”) of its election to discontinue additional development contributions under the Contribution and Stock Purchase Agreement dated April 18, 2023 (the “Agreement”).

View on SEC.gov

Browse all material agreements →

Anteris Technologies Global Corp. filing history →

Source: SEC EDGAR

accession 0001140361-26-017846

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.